Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells [1]

Blood

Volumn 104, Issue 10, 2004, Pages 3408-3409

  Fehse, Boris ^a   Ayuk, Francis A ^b   Kröger, Nicolaus ^b   Fang, Lubin ^b   Kühlcke, Klaus ^b   Heinzelmann, Marion ^b   Zabelina, Tatjana ^b   Fauser, Axel A ^b   Zander, Axel R ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GANCICLOVIR; RECOMBINANT DNA; RETROVIRUS VECTOR;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; FEMALE; GENE TRANSFER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; LYMPHOCYTE DEPLETION; MALE; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RISK FACTOR; SUICIDE GENE; SUICIDE GENE THERAPY; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 8644237493     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2813     Document Type: Letter

References (8)

1. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997;276:1719-1724.
2. Tiberghien P, Ferrand C, Lioure B, et al. Administration of herpes simplex-thymidine kinase-expressing donor T-cells with a T-cell-depleted allogeneic marrow graft. Blood. 2001;97:63-72.
3. Zander AR. Use of genetically modified donor T cells in allogeneic bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT): a multi-center phase I-II clinical study [clinical protocol online]. Available at: http://www.zks.uni-freiburg.de/dereg.html. Accessed on July 21, 2004.
4. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2003;348:255-256.
5. Kühlcke K, Fehse B, Schilz A, et al. Highly efficient retroviral gene transfer based on centrifugation-mediated vector pre-loading of tissue culture vessels. Mol Ther. 2002;5:473-478.
6. Frank O, Rudolph C, Heberlein C, et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability. Blood. Prepublished on August 12, 2004, as DOI 10.1182/blood-2004-03-0852.
7. Fehse B, Frerk O, Goldmann M, et al. Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69). Br J Haematol. 2000;109:644-651.
8. Urbano-Ispizua A, Rozman C, Pimentel P, et al. The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings. Blood. 2001;97:383-387.